Perioperative administration of recombinant activated factor VII in a Glanzmann's thrombasthenia patient with platelet refractoriness: case report.

Abstract

Glanzmann's Trombasthenia (GT) is a genetic disorder, that develops with a tendency toward bleeding and is characterized by the absence or decrease in platelet aggregation. Surgical bleeding may be difficult to control. Platelet transfusion is the main treatment, albeit refractoriness can occur. We describe the case of a patient with GT and platelet refractoriness, who was submitted to radical prostatectomy and dental extraction. The perioperative treatment with apheresis platelet concentrate and activated recombinant factor seven allowed the procedures to be performed uneventfully. We discuss the complexity of the case and the treatment option.

• Authors: Flora Margarida Barra Bisinotto, Laura Bisinotto Martins, Giovanini Pires de Camargos, Marcelo de Paula Bianco
• Journal: Brazilian journal of anesthesiology (Elsevier) (Braz J Anesthesiol) 2022 Nov-Dec Vol. 72 Issue 6 Pg. 823-825 ISSN: 2352-2291 [Electronic] Brazil
• PMID: 34852265 (Publication Type: Case Reports)
• Copyright: Copyright © 2021. Published by Elsevier Editora Ltda.

Chemical References

• Factor VIIa

Topics

• Male
• Humans
• Thrombasthenia (complications, surgery)
• Factor VIIa (therapeutic use)
• Platelet Transfusion
• Hemorrhage